Nav: Home

Current Vaccines News and Events

Current Vaccines News and Events, Vaccines News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Researchers develop high-performance cancer vaccine using novel microcapsules
Scientists from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed a new therapeutic tumor vaccine based on self-healing polylactic acid microcapsules, which can efficiently activate the immune system and inhibit tumor development. (2020-05-22)
When developing vaccines against COVID-19, 'fast is slow, and slow is fast'
Bypassing clinical trials for a potential SARS-CoV-2 vaccine would be ''catastrophic,'' says Science Advances deputy editor Douglas Green in this Editorial. (2020-05-22)
The self-synthesizing ribosome
As the cell's protein factory, the ribosome is the only natural machine that manufactures its own parts. (2020-05-21)
Immunity to coronaviruses: What do we know so far?
Written by top UK virologists, the article discusses the existing knowledge about immune responses to SARS-CoV-2 and other coronaviruses, and how this could be used to inform virus control strategies. (2020-05-21)
BIDMC-developed vaccines protect against COVID-19 in non-human primates, study finds
A pair of new studies led by researchers at Beth Israel Deaconess Medical Center (BIDMC) sheds new light on two questions: whether vaccines will prevent infection with COVID-19, and whether individuals who have recovered from COVID-19 are protected against re-exposure. (2020-05-20)
Macaques show protective immunity against SARS-CoV-2 after infection or after vaccine
Two new studies in macaques offer hope that humans could develop protective immunity against SARS-CoV-2, either as the result of a natural infection or by way of a vaccine. (2020-05-20)
Malaria vaccines based on engineered parasites show safety, signs of efficacy
Two vaccines for malaria based on genetically engineered malaria parasites have been found to be safe in humans and show preliminary signs of protection, according to a pair of new phase 1/2a clinical trials. (2020-05-20)
New imaging analysis pipeline could aid in drug and vaccine development
A new paper introduces a method to effectively analyze data from lattice light-sheet microscopy, used to closely examine individual cells, such as T-cells, in 4D. (2020-05-20)
How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization. (2020-05-19)
Viral infection: Early indicators of vaccine efficacy
Ludwig-Maximilians-Universität (LMU) in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies. (2020-05-15)
Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines. (2020-05-14)
New approach to design functional antibodies for precision vaccines
A new approach to de novo protein design dubbed 'TopoBuilder' allows researchers to develop complex antigens that, when used in vaccines, elicit antibody responses that target the weaknesses in some of the most intractable viral pathogens, including respiratory syncytial virus (RSV). (2020-05-14)
In victory over polio, hope for the battle against COVID-19
Medicine's great triumph over polio holds out hope we can do the same for COVID-19, two researchers say. (2020-05-13)
Molecular signatures can predict the efficacy of malaria vaccines
Molecular signatures before and after immunization can predict vaccine-induced protection, according to a study by ISGlobal, an institution supported by 'la Caixa.' The study analysed the gene expression in peripheral blood cells from individuals immunized with the first malaria vaccine (Mosquirix or RTS,S) and another experimental malaria vaccine. (2020-05-13)
SARS-CoV-2: A new song recalls an old melody
Important lessons learned from the Severe Acute Respiratory Syndrome (SARS) outbreak of 2002-2003 could inform and guide vaccine design for COVID-19 according to University of Melbourne Professor Kanta Subbarao, Director of the WHO Centre for Reference and Research on Influenza at the Doherty Institute. (2020-05-13)
The challenges of developing a safe and effective COVID-19 vaccine
Researchers at Baylor College of Medicine and colleagues identify critical points to pay close attention to when designing and developing COVID-19 vaccines. (2020-05-12)
Fred Hutch, NIH experts outline plan for COVID-19 vaccines
In a perspective published online May 11 by the journal Science, Fred Hutch's Dr. (2020-05-11)
New HIV vaccine strategy strengthens, lengthens immunity in primates
Investigators at the Stanford University School of Medicine and several other institutions have shown that a new type of vaccination can substantially enhance and sustain protection from HIV. (2020-05-11)
Development of effective COVID-19 vaccines will require unprecedented collaboration
A diversity of vaccine approaches, not a single SARS-CoV-2 vaccine or vaccine platform, must be pursued to meet the global need to protect from the continued threat of the SARS-CoV-2 virus, write Lawrence Corey, John R. (2020-05-11)
NIH experts: Coordinated strategy to accelerate COVID-19 vaccine candidates is key
A harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate vaccines to prevent COVID-19 is essential, scientific leaders write in a perspective published today in Science. (2020-05-11)
KIST-CUK research team develops vaccine platform applicable to various viruses
MERS, which struck South Korea in a 2015 outbreak, was caused by a coronavirus--the same family of viruses that is responsible for COVID-19. (2020-05-08)
Perspective: Rapid COVID-19 vaccine development
When seeking the fastest pathway to a vaccine to prevent coronavirus disease 19 (COVID-19), defining the stakes and potential hurdles is critical, says Barney Graham in this Perspective. (2020-05-08)
Repurposing existing drugs for COVID-19 offers a more rapid alternative to a vaccine
Repurposing existing medicines focused on known drug targets is likely to offer a more rapid hope of tackling COVID-19 than developing and manufacturing a vaccine, argue an international team of scientists in the British Journal of Pharmacology today. (2020-05-07)
Towards antibodies against COVID-19
The lab of Xavier Saelens (VIB-UGent Center for Medical Biotechnology) announces the isolation and characterization of a unique antibody that can bind to the virus that causes COVID-19 (SARS-CoV-2). (2020-05-06)
Inactivated vaccine candidate protects macaques from SARS-CoV-2 infection
In mice, rats, and nonhuman primates, a newly developed SARS-CoV-2 virus vaccine candidate induced antibodies that neutralized several different SARS-CoV-2 strains. (2020-05-06)
Discovery of bacterial enzyme activity could lead to new sugar-based drugs
Researchers from DTU have revealed the structure of an enzyme that can convert low-cost sugars into hard-to-produce alpha-GalNAc sugars with therapeutic properties for e.g. cancer drugs. (2020-05-04)
Mapping glycan composition on the SARS-CoV-2 spike protein to inform vaccine design
Using high-resolution mass spectrometry, researchers have mapped glycan-processing states of the spike protein complex that allows the SARS-CoV-2 virus to infect human cells - finding that SARS-CoV-2 S glycans differ from typical host glycan processing, which may have implications in vaccine design. (2020-05-04)
To prevent antimicrobial resistance, vaccinate the world's kids
Childhood vaccination may be a powerful tool in the fight against antimicrobial resistance in low- and middle-income countries, finds a new analysis led by researchers University of California, Berkeley. (2020-04-29)
'Dirty' mice could help make a more effective flu vaccine
Studying mice that have been exposed to other illnesses could help make vaccine development processes more reflective of real-world conditions and lead to better vaccines, according to a new study. (2020-04-27)
COVID-19 and pregnancies: What we know
Amid the rapidly evolving global coronavirus disease 2019 (COVID-19) pandemic that has already had profound effects on public health and medical infrastructure across the globe, many questions remain about its impact on child health. (2020-04-27)
The most promising strategies for defeating coronavirus: A review study
Experts from UNC Chapel Hill review possible clinical approaches from antivirals to gene therapy against the virus responsible for COVID-19 and related diseases. (2020-04-24)
Researchers uncover mechanisms of protective antibody response during Marburg infection
A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel mechanisms that contribute protection against the disease, according to the latest findings of a collaborative team led by The University of Texas Medical Branch at Galveston and Vanderbilt University Medical Center. (2020-04-21)
Researchers develop new microneedle array combination vaccine delivery system
In parallel to their current work on a potential coronavirus vaccine, researchers at the University of Pittsburgh School of Medicine have developed a new vaccine delivery system for vaccines using live or attenuated viral vectors: a finger-tip sized patch that contains 400 tiny needles, each just half of one millimeter. (2020-04-21)
Cochrane Review confirms effectiveness of MMR vaccines
New evidence published in the Cochrane Library today finds MMR, MMRV and MMR+V vaccines are effective and that they are not associated with increased risk of autism. (2020-04-20)
Elderly patients with pneumonia twice as likely to die as those with broken hips, yet underestimate the danger of pneumonia
Elderly patients who are hospitalised with pneumonia are twice as likely to die as those hospitalised with hip fractures -- yet many elderly people fail to accurately assess their risk of pneumonia, concludes research due to be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). (2020-04-17)
New universal Ebola vaccine may fight all four virus species that infect humans
Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests show might neutralize all four species of these deadly viruses infecting people in recent outbreaks, mainly in Africa. (2020-04-16)
Psychology research: Antivaxxers actually think differently than other people
As vaccine skepticism has become increasingly widespread, two researchers in the Texas Tech University Department of Psychological Sciences have suggested a possible explanation. (2020-04-10)
Newly emerged enterovirus-A71 C4 isolates may be more virulent than B5 in northern Vietnam
Researchers from Kanazawa University have found a new sublineage of enterovirus A71 (EV-A71) C4 subgenotype with two possible recombinant strains during the 2015-16 outbreak of hand-foot-and-mouth disease in Hanoi, northern Vietnam. (2020-04-09)
Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19. (2020-04-07)
Development of new system for combatting COVID-19 that can be used for other viruses
A team working to combat the COVID-19 virus has a system that will unlock researchers' ability to more quickly develop and evaluate developing vaccines, diagnose infected patients and explore whether or how the virus has evolved. (2020-04-06)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.